Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Allo HSCT Using RIC and PTCy for Hematological Diseases
- Status
- RECRUITING
- Phase
- PHASE2
Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
- Status
- RECRUITING
- Phase
- PHASE2
A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study Using Subject-specific MRD to Adopt Treatment After HSCT for Subjects With MDS
- Status
- RECRUITING
- Phase
- PHASE2
Trial of Cladribine and Low-Dose Cytarabine (LoDAC) Alternating With Decitabine vs. Hypomethylating Agents (HMA) Plus Venetoclax as Frontline Therapy for AML or High-Grade MDS in Patients Unfit for Intensive Induction
- Status
- WITHDRAWN
- Phase
- PHASE2
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
- Status
- RECRUITING
- Phase
- NA
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML
- Status
- RECRUITING
- Phase
- PHASE1
Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS
- Status
- RECRUITING
- Phase
- PHASE1
CD34+ Enriched Transplants to Treat Myelodysplastic Syndrome
- Status
- SUSPENDED
- Phase
- PHASE2
A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics
- Status
- TERMINATED
- Phase
- PHASE1
First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Expanded Access Program (EAP) for Galinpepimut-S (GPS) in Patients Diagnosed With AML or MDS
- Status
- AVAILABLE
- Phase
- N/A
Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
- Status
- RECRUITING
- Phase
- N/A
Unrelated Umbilical Cord Blood Stem Cell Combined With Azacitidine Based Treatment for Advanced MDS,CMML-2 and sAML
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2